| 98 |
The myokine Fibcd1 is an endogeneous determinant of myofiber size and mitigates cancer induced myofiber atrophy
|
Kim Hyun Jun |
78 |
2023-03-21 |
|
| 97 |
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target
|
성현지 |
95 |
2023-03-15 |
|
| 96 |
Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth f
|
김준형 |
89 |
2023-03-15 |
|
| 95 |
Cancer-Induced Muscle Wasting Requires p38b MAPK Activation of p300
|
김선욱 |
76 |
2023-02-23 |
|
| 94 |
Progression and Differentiation of Alveolar Rhabdomyosarcoma Is Regulated by PAX7 Transcription Factor—Significance of Tumor Subclones
|
장은미 |
62 |
2023-02-01 |
|
| 93 |
Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGFPI3KAKT signaling
|
Kim Hyun Jun |
69 |
2023-01-16 |
|
| 92 |
The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation
|
김준형 |
105 |
2023-01-11 |
|
| 91 |
Development of a traditional Chinese medicine‐based agent for the treatment of cancer cachexia
|
김선욱 |
79 |
2023-01-04 |
|
| 90 |
Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy
|
이상훈 |
811 |
2022-02-25 |
|
| 89 |
SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function
|
장은미 |
506 |
2022-02-25 |
|
